Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CYP2B6 and OPRM1 polymorphisms on postoperative sufentanil analgesia after knee arthroscopy
ChiCTR2300070098Phase 4Not yet recruiting
- Sponsor
- Suzhou Science and Technology Town Hospital
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil in postoperative pain, sponsored by Suzhou Science and Technology Town Hospital. Primary endpoint: Postoperative pain level. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300070098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070098.